Literature DB >> 18763316

Effects of RNA interference-induced tryptase down-regulation in P815 cells on IL-6 and TNF-alpha release of endothelial cells.

Yi-feng Jiang1, Feng-di Zhao, Xiao-bo Li, Yan-xia Ning, Xiu-ling Zhi, Rui-zhe Qian, Lian-hua Yin.   

Abstract

OBJECTIVE: To explore the effects of down-regulated tryptase expression in mast cells on the synthesis and release of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) of vascular endothelial cells.
METHODS: Tryptase-siRNA (small-interfering RNA) vector was constructed to inhibit tryptase expression in P815 cells. The medium of P815 cells treated by the tryptase-siRNA (RNAi-P815 group) or pure vector (P815 group) was collected and used to culture bEnd.3 cells. The messenger RNAs (mRNAs) of IL-6 and TNF-alpha in bEnd.3 cells and their protein levels in the medium were measured by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively.
RESULTS: IL-6 and TNF-alpha mRNAs in bEnd.3 cells cultured in RNAi-P815-conditioned medium decreased significantly compared to those in P815-conditioned medium. Consistently, IL-6 and TNF-alpha protein levels in the medium of bEnd.3 of RNAi-P815 group were lower than those of P815 group.
CONCLUSION: Reduced tryptase expression significantly inhibited the synthesis and release of IL-6 and TNF-alpha in vascular endothelial cells. RNA interference targeting tryptase expression may be a new anti-inflammatory strategy for vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763316      PMCID: PMC2491696          DOI: 10.1631/jzus.B0810188

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  20 in total

Review 1.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

Review 2.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

3.  Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol.

Authors:  Miriam Lee; Christian P Sommerhoff; Arnold von Eckardstein; Frank Zettl; Hans Fritz; Petri T Kovanen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

Review 4.  Endothelial function as a determinant of vascular function and structure: a new therapeutic target.

Authors:  G H Gibbons
Journal:  Am J Cardiol       Date:  1997-03-06       Impact factor: 2.778

5.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor.

Authors:  S J Warner; P Libby
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

Review 6.  Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibroblasts: implications for vascular protection.

Authors:  O Eickelberg; M Roth; L H Block
Journal:  Int J Cardiol       Date:  1997-12-31       Impact factor: 4.164

7.  Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1.

Authors:  D M Smalley; J H Lin; M L Curtis; Y Kobari; M B Stemerman; K A Pritchard
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

8.  Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells.

Authors:  Toshiaki Sendo; Tomoko Sumimura; Yoshinori Itoh; Takeshi Goromaru; Keisei Aki; Takahisa Yano; Masahiro Oike; Yushi Ito; Shuji Mori; Masahiro Nishibori; Ryozo Oishi
Journal:  Cell Signal       Date:  2003-08       Impact factor: 4.315

9.  Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: possible relevance to multiple sclerosis.

Authors:  Vivian Malamud; Ady Vaaknin; Oded Abramsky; Michal Mor; Laurence E Burgess; Ahmi Ben-Yehudah; Haya Lorberboum-Galski
Journal:  J Neuroimmunol       Date:  2003-05       Impact factor: 3.478

10.  Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.

Authors:  Claudia Monaco; Evangelos Andreakos; Serafim Kiriakidis; Claudia Mauri; Colin Bicknell; Brian Foxwell; Nicholas Cheshire; Ewa Paleolog; Marc Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

View more
  2 in total

1.  Allograft rejection-related gene expression in the endothelial cells of renal transplantation recipients after cytomegalovirus infection.

Authors:  Yang Li; Hang Yan; Wu-jun Xue; Pu-xun Tian; Xiao-ming Ding; Xiao-ming Pan; Xin-shun Feng; Xiao-hui Tian; He-li Xiang; Jun Hou
Journal:  J Zhejiang Univ Sci B       Date:  2009-11       Impact factor: 3.066

2.  RNA interference against interleukin-5 attenuates airway inflammation and hyperresponsiveness in an asthma model.

Authors:  Shao-xing Chen; Feng-ying Huang; Guang-hong Tan; Cai-chun Wang; Yong-hao Huang; Hua Wang; Song-lin Zhou; Fan Chen; Ying-ying Lin; Jun-bao Liu
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.